Cheaper alternative to licensed drug for treating eye disease has similar side-effects

(Wiley) Health policies which favour using ranibizumab for treating eye disease in older people over safety concerns for a cheaper alternative should take account of a new Cochrane Review published today.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news